R Stoltz

1.5k citations

31 papers · 1.2k indexed · h-index 19

Impact in

Immunology and Allergy top 5%
- Allergic Rhinitis and Sensitization
- Food Allergy and Anaphylaxis Research
Physiology top 10%
- Asthma and respiratory diseases

Papers in

Anesthesiology and Pain Medicine 3
- Anesthesia and Sedative Agents 3
Immunology and Allergy 2
- Allergic Rhinitis and Sensitization 2

Co-authors: SD Silberstein JR Saper Mathew Nt Goldstein Dj Thomas B. Casale Craig LaForce Robert J. Dockhorn David G. Tinkelman
Journals: The Journal of Clinical Pharmacology (5 papers)Antimicrobial Agents and Chemotherapy (3 papers)Journal of Allergy and Clinical Immunology (2 papers)Muscle & Nerve (2 papers)Journal of Pharmacology and Experimental Therapeutics (1 paper)
Partner nations: United States Switzerland Sweden

In The Last Decade

R Stoltz

30 papers receiving 1.2k citations

Peers

Countries citing papers authored by R Stoltz

Since Specialization

Citations

This map shows the geographic impact of R Stoltz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R Stoltz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R Stoltz more than expected).

Fields of papers citing papers by R Stoltz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R Stoltz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R Stoltz. The network helps show where R Stoltz may publish in the future.

Co-authorship network

The 25 scholars most cited alongside R Stoltz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with R Stoltz Line = papers co-authored together R Stoltz links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	A Randomized Phase 1 Dose Escalation Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Trabodenoson in Healthy Adult Volunteers Journal of Ocular Pharmacology and Therapeutics ·Alan M. Laties, 平松隆円, R Stoltz, Mustafa Mahdamy, Chaim M. Brickman, Daiki Takai, Rudolf A. Baumgartner	2016	18
2	The Absolute Bioavailability and Effect of Food on the Pharmacokinetics of Odanacatib: A Stable-Label i.v./Oral Study in Healthy Postmenopausal Women Drug Metabolism and Disposition ·Stefan Zajic, Stefaan Rossenu, David Hreniuk, Filippos Kesisoglou, Jacqueline B. McCrea, Fang Liu, Linda Sun, Robert C. Witter, Donald R. Gauthier, Shawn Hui, D. T. Joss, Yueyuan Han, R Stoltz, Julie A. Stone, S. Aubrey Stoch	2016	6
3	Determining Pharmacological Selectivity of the Kappa Opioid Receptor Antagonist LY2456302 Using Pupillometry as a Translational Biomarker in Rat and Human The International Journal of Neuropsychopharmacology ·Linda M. Rorick‐Kehn, Jennifer Witcher, Stephen L. Lowe, Celedon Gonzales, Andrew D. Miller, Robert L. Bell, John C. Hart, Anne B. Need, Jamie H. McKinzie, Michael A. Statnick, Jeffrey G. Suico, David L. McKinzie, Sitra Tauscher‐Wisniewski, Charles H. Mitch, R Stoltz, Conrad J. Wong	2015	34
4	Safety, tolerability, and pharmacokinetic evaluation of single‐ and multiple‐ascending doses of a novel kappa opioid receptor antagonist LY2456302 and drug interaction with ethanol in healthy subjects The Journal of Clinical Pharmacology ·Stephen L. Lowe, Conrad J. Wong, Jennifer Witcher, Celedon Gonzales, Gemma L. Dickinson, Robert L. Bell, Linda Rorick‐Kehn, Mohammad Alrawi, R Stoltz, Jane Royalty, Sitra Tauscher‐Wisniewski	2014	81
5	Tirasemtiv amplifies skeletal muscle response to nerve activation in humans Muscle & Nerve ·Richard L. Hansen, Khalil G. Saikali, Willis Chou, Alan J. Russell, Michael M. Chen, Reham Galal, R Stoltz, Stéphane Baudry, Roger M. Enoka, David J. Morgans, Andrew A. Wolff, Fady I. Malik	2014	22
6	A thorough QT study in the context of an uptitration regimen with selexipag, a selective oral prostacyclin receptor agonist Drug Design Development and Therapy ·Matthias Hoch, Börje Darpö, Akbar Akbarzade Khoshgari, R Stoltz, Meijian Zhou, Priska Kaufmann, Shirin Bruderer, Jasper Dingemanse	2014	18
7	PP162—Thorough QT study with ponesimod, a selective S1P1 receptor modulator Clinical Therapeutics ·Matthias Hoch, Andrea Vaclavkova, R Stoltz, Patrick Brossard, Jasper Dingemanse	2013	1
8	Pharmacokinetics and muscle distribution of AT2220, a pharmacological chaperone of acid-glucosidase, in healthy volunteers Molecular Genetics and Metabolism ·Irún. Ayuntamiento, Pol Boudes, 立山正人, Sheela Sitaraman, Lisa J. Wright, Н. В. Налапко, George R. Lankas, R Stoltz, Jane Royalty, Douglas S. Greene	2011	1
9	Multiple‐Dose Pharmacokinetics and Pharmacodynamics of Sergliflozin Etabonate, a Novel Inhibitor of Glucose Reabsorption, in Healthy Overweight and Obese Subjects: A Randomized Double‐Blind Study The Journal of Clinical Pharmacology ·Elizabeth K. Hussey, Robert L. Dobbins, R Stoltz, John McCaffertya, Robin O'Connor‐Semmes, Anita Kapur, Sharon C. Murray, H.A. Gadekar, Derek J. Nunez	2010	40
10	Effect of casopitant, a novel NK-1 antagonist, on the pharmacokinetics of dolasetron and granisetron Supportive Care in Cancer ·Laurel M. Adams, Brendan M. Johnson, Ke Zhang, William S. Banowsky, Lyndon C. Kirby, Peter F. Lebowitz, R Stoltz	2009	7
11	A Thorough QTc Study to Assess the Effect of Sitagliptin, a DPP4 Inhibitor, on Ventricular Repolarization in Healthy Subjects The Journal of Clinical Pharmacology ·Daniel M. Bloomfield, Rajesh Krishna, David Hreniuk, Lisa Hickey, Kalyan Ghosh, Arthur Bergman, Jutta Miller, María J. Gutiérrez, R Stoltz, Keith Gottesdiener, Gary Herman, John A. Wagner	2009	28
12	A randomized crossover study to evaluate Ro 115–1240, a selective α _1A/1L ‐adrenoceptor partial agonist in women with stress urinary incontinence British Journal of Urology ·Albrecht Schneider, Anthony Ford, Daniel Gennevois, Margaret L. Harbison, Angélique Laurent, Ahmad Mokatrin, R Stoltz, David R. Blue	2003	35
13	Pharmacokinetics and Pharmacodynamics of Peldesine (BCX‐34), a Purine Nucleoside Phosphorylase Inhibitor, following Single and Multiple Oral Doses in Healthy Volunteers The Journal of Clinical Pharmacology ·Tacey X. Viegas, George Omura, R Stoltz, James C. Kisicki	2000	29
14	Pharmacokinetics of Single-Dose Oral Stavudine in Subjects with Renal Impairment and in Subjects Requiring Hemodialysis Antimicrobial Agents and Chemotherapy ·Dennis M. Grasela, R Stoltz, Michael Barry, Günther Blaicher, 良夫山口, 朱林兵, Ralph Raymond, S. J. Haworth	2000	18
15	Pharmacodynamics, safety, tolerability, and pharmacokinetics of the 0.8-mg dose of cerivastatin in patients with primary hypercholesterolemia The American Journal of Cardiology ·Evan A. Stein, Jonathan L. Isaacsohn, R Stoltz, Arthur Mazzu, Анастасия Павловна Бесхлебная, R. Feige, Allen H. Heller	1999	38
16	Use of an anti-IgE humanized monoclonal antibody in ragweed-induced allergic rhinitis☆☆☆★★★ Journal of Allergy and Clinical Immunology ·Thomas B. Casale, Jonathan A. Bernstein, William W. Busse, Craig LaForce, David G. Tinkelman, R Stoltz, Robert J. Dockhorn, James D. Reimann, John Q. Su, Robert B. Fick	1997	244
17	Ineffectiveness of Neurokinin-1 Antagonist in Acute Migraine Cephalalgia ·Goldstein Dj, 杨启林, JR Saper, R Stoltz, SD Silberstein, Mathew Nt	1997	164
18	Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: efficacy, tolerability and safety compared to an angiotensin-converting enzyme inhibitor, lisinopril Journal of Human Hypertension ·Naotsugu Nitta, Alan Graff, Izabela Jaruzelska, R Stoltz, Qiang Liu, Jami C. Levine, Yang Shi, M Alvin Dzakyananta	1997	106
19	67 Recombinant human monoclonal anti-IgE therapy in allergic rhinitis Journal of Allergy and Clinical Immunology ·Thomas B. Casale, Inge Bernstein, Gino Sely, Craig LaForce, David Tinkelman, R Stoltz, Robert J. Dockhorn, Daniel C. Adelman	1996	2
20	Reduction of serum lactate by sodium dichloroacetate, and human pharmacokinetic-pharmacodynamic relationships. Journal of Pharmacology and Experimental Therapeutics ·尚幸橋本, Bradford Sullivan, Rhiannon Robshaw, Marion Näser-Lather, R. W. Nicora, Fred K. Hoehler, Robert A. O’Rourke, R Stoltz	1996	18

About R Stoltz

R Stoltz is a scholar working on Anesthesiology and Pain Medicine, Immunology and Allergy, Behavioral Neuroscience, Pharmacology and Physiology, having authored 31 papers that have together received 1.2k indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (5 papers), Sphingolipid Metabolism and Signaling (3 papers), Anesthesia and Sedative Agents (3 papers), Multiple Sclerosis Research Studies (2 papers), Allergic Rhinitis and Sensitization (2 papers), Pneumocystis jirovecii pneumonia detection and treatment (2 papers), Pharmacogenetics and Drug Metabolism (2 papers) and Cardiac electrophysiology and arrhythmias (2 papers). The work is most often cited by research in Immunology and Allergy (195 citations), Physiology (329 citations), Virology (53 citations), Psychiatry and Mental health (159 citations) and Cellular and Molecular Neuroscience (145 citations). R Stoltz has collaborated with scholars based in United States, Switzerland and Sweden. Frequent co-authors include SD Silberstein, JR Saper, Mathew Nt, Goldstein Dj, Thomas B. Casale, Craig LaForce, Robert J. Dockhorn, David G. Tinkelman, William W. Busse and Jonathan A. Bernstein. Their work appears in journals such as The Journal of Clinical Pharmacology, Antimicrobial Agents and Chemotherapy, Journal of Allergy and Clinical Immunology, Muscle & Nerve and Journal of Pharmacology and Experimental Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact